374
Answers and Solutions
Chapter 14: Capital Structure and Leverage
14-6 Biotechnology companies use relatively little debt because their industries tend to be cyclical,
14-7 EBIT depends on sales and operating costs that generally are not affected by the firm’s use of
14-8 Expected EPS is generally measured as EPS for the coming years, and we typically do not reflect
in this calculation any bankruptcy-related costs. Also, EPS does not reflect (in a major way) the
14-9 The tax benefits from debt increase linearly, which causes a continuous increase in the firm’s
14–10 With increased competition after the breakup of AT&T, the new AT&T and the seven Bell
operating companies’ business risk increased. With this component of total company risk
14–11 The firm may want to assess the asset investment and financing decisions jointly. For instance,